Methods of treating p150,95-mediated inflammation and ICAM-1-mediated viral infection
US6030947A · kind A · utility
9Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1997 |
| Grant date | Feb 29, 2000 |
| Priority date | — |
| Expiry date | Mar 19, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention concerns the cloning of the alpha-subunit of the p150,95 leukocyte adhesion receptor molecule. The invention also concerns the alpha-subunit of p150,95, as well as fragments of this receptor molecule. The invention further pertains to the diagnostic and therapeutic uses for such molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.